Vivoryon Therapeutics’ EUR25 Million Private Placement

NautaDutilh advised Vivoryon Therapeutics in its private placement.Vivoryon Therapeutics, a clinical-stage company committed to discovering and developing small molecule medicines to regulate the activity and stability…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Georgio Naffaa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here